[144] uniQure N.V. SEC Filing

Rhea-AI Filing Summary

Form 144 filed relating to proposed sale of uniQure N.V. (QURE) ordinary shares. The notice reports a proposed sale of 15,000 ordinary shares through Citigroup Global Markets on 09/26/2025 with an aggregate market value of $825,000.00 and total shares outstanding noted as 54,866,930. The shares were acquired and to be sold on 09/26/2025 via a stock option exercise and sale pursuant to a 10b5-1 plan, with payment in cash. The filer also reported a prior sale of 3,000 shares on 09/24/2025 generating $120,119.00 in gross proceeds.

Insights

Securities Analyst

TL;DR: Insider sale under a 10b5-1 plan totaling 15,000 shares; size appears modest relative to outstanding shares.

The filing documents a proposed sale of 15,000 uniQure ordinary shares valued at $825,000 executed through Citigroup on 09/26/2025, following a stock option exercise and under a stated 10b5-1 plan. With 54,866,930 shares outstanding, the proposed sale represents approximately 0.027% of the outstanding share count, indicating limited dilution or near-term market impact from this single transaction. The disclosure of a recent 3,000-share sale on 09/24/2025 provides additional context on recent insider selling activity but does not by itself indicate a material change to the company capital structure.

Compliance/Risk Analyst

TL;DR: Filing complies with Rule 144 and notes a 10b5-1 plan; no undisclosed material nonpublic information is asserted.

The filer certifies absence of material nonpublic information and indicates reliance on a 10b5-1 trading arrangement for the option exercise and sale. The form identifies the broker and nature of payment as cash, and shows recent related sales in the prior 3 months. From a compliance perspective, required fields for a Rule 144 notice are present in the submission. The filing itself is a routine disclosure of insider liquidity activity without additional risk events or regulatory flags disclosed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ORDINARY SHARES	CITIGROUP GLOBAL MARKETS 390 GREENWICH ST NEW YORK NY 10013	15000	825000.00	54866930	09/26/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ORDINARY SHARES	09/26/2025	STOCK OPTION EXERCISE AND SALE PURSUANT TO 10B51 PLAN	UNIQURE NV			15000	09/26/2025	CASH

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
CHRISTIAN KLEMT PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP	ORDINARY SHARES	09/24/2025	3000	120119.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for uniQure (QURE) disclose?

The form discloses a proposed sale of 15,000 ordinary shares via Citigroup on 09/26/2025, valued at $825,000.00, acquired and sold following a stock option exercise under a 10b5-1 plan.

Who is the seller named in the Form 144 for QURE?

A prior seller listed in the filing is Christian Klemt with an address in Amsterdam; the filing shows related sales activity including 3,000 shares sold on 09/24/2025.

How many uniQure shares are outstanding according to the filing?

The filing reports 54,866,930 shares outstanding.

Was the sale executed under a trading plan or instruction?

Yes. The securities were acquired and to be sold on 09/26/2025 via a stock option exercise and sale pursuant to a 10b5-1 plan, with payment in cash.

What broker is handling the proposed sale noted in the Form 144?

The broker named is Citigroup Global Markets, 390 Greenwich St, New York, NY 10013.